Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
133.06
1.75 (1.33%)
At close: Aug 15, 2025, 1:28 PM
Neurocrine Biosciences Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for NBIX stock have an median target of 165, with a low estimate of 139 and a high estimate of 189. The median target predicts an increase of 24.00% from the current stock price of 133.06.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 139 | 164.53 | 165 | 189 |
| Change | 4.46% | 23.65% | 24.00% | 42.04% |
Latest Analyst Insight Report
RBC Capital retains an Outperform rating on Neuroc... Unlock content with Pro Subscription
Updated Jul 31, 2025
| Rating | Mar 25 | Apr 25 | May 25 | Jun 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 4 | 0 | 2 | 1 |
| Buy | 1 | 6 | 2 | 1 | 7 | 0 |
| Hold | 0 | 0 | 1 | 0 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 6 | 7 | 1 | 10 | 1 |
Financial Forecast this Year
Revenue This Year
2.79B
from 2.36B
Increased by 18.4%
Revenue Next Year
3.2B
from 2.79B
Increased by 14.7%
EPS This Year
4.55
from 3.4
Increased by 33.8%
EPS Next Year
6.63
from 4.55
Increased by 45.7%